LMR Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

LMR Partners’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-80,000	Closed	-$1.85M	–	1164
2020 Q4	$1.85M	Buy	+80,000	New	+$1.01M	0.03%	225

LMR Partners's PRVL Position: Q1 2021 in Review

LMR Partners sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 80,000 shares — an estimated $1.85M sold.

LMR Partners first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $1.85M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

LMR Partners reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
LMR Partners sold 80,000 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $1.85M.
LMR Partners first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
LMR Partners's Prevail Therapeutics Inc. Common Stock position peaked at $1.85M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on LMR Partners's 13F filing for Q1 2021, filed 17 May 2021.